Compare Match Group Inc (MTCH) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Match Group Inc vs Regeneron Pharmaceuticals Inc — how do they compare? Match Group Inc trades at $39.02 (market cap $9.10B), while Regeneron Pharmaceuticals Inc trades at $670 (market cap $70.47B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 7.7× Match Group Inc's market cap, and Match Group Inc pays the higher dividend (2.05%). Which is the better fit depends on your goals.
| MTCH | REGN | |
|---|---|---|
Market Cap | $9.10B | $70.47B |
Sector | Media | Health |
52-Week High | $40.29 | $812.27 |
52-Week Low | $28.90 | $545.46 |
Enterprise Value | $12.05B | $64.42B |
Dividend Yield | 2.05% | 0.56% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Match Group Inc
Match Group is a provider of online dating products. The firm became public in 2015 and was more than 80% owned by IAC/InterActiveCorp until IAC spun it off in the second quarter of 2020. The company has a vast portfolio of different online dating service providers, including Tinder, Match.com, OkCupid, Plenty of Fish, and Meetic. Match Group has more than 45 brands of online dating sites and/or apps, from which it generates user fee revenue (95%) and advertising revenue (5%).
Read more on MTCH →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
